Edition:
United Kingdom

Abbott Sees FY 2019 Earnings Per Share $1.80 To $1.90 From Continuing Operations


Wednesday, 23 Jan 2019 

Jan 23 (Reuters) - Abbott Laboratories ::ABBOTT REPORTS 2018 RESULTS AND ISSUES STRONG FORECAST FOR 2019.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $3.15 TO $3.25 FROM CONTINUING OPERATIONS.SEES Q1 ADJUSTED EARNINGS PER SHARE $0.60 TO $0.62 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.SEES FY 2019 GAAP EARNINGS PER SHARE $1.80 TO $1.90 FROM CONTINUING OPERATIONS.SEES Q1 2019 GAAP EARNINGS PER SHARE $0.25 TO $0.27 FROM CONTINUING OPERATIONS.Q4 ADJUSTED EARNINGS PER SHARE $0.81 FROM CONTINUING OPERATIONS.Q4 GAAP EARNINGS PER SHARE $0.37 FROM CONTINUING OPERATIONS.Q4 EARNINGS PER SHARE ESTIMATE $0.81 -- REFINITIV IBES DATA.QTRLY TOTAL PEDIATRIC SALES $1,013 MILLION VERSUS $1,000 MILLION REPORTED LAST YEAR.QTRLY SALES OF $7.77 BILLION VERSUS $7.59 BILLION.Q4 REVENUE VIEW $7.82 BILLION -- REFINITIV IBES DATA.FOURTH-QUARTER WORLDWIDE SALES OF $7.8 BILLION INCREASED 2.3 PERCENT ON A REPORTED BASIS AND 6.4 PERCENT ON AN ORGANIC BASIS.ISSUING FULL-YEAR 2019 GUIDANCE FOR ORGANIC SALES GROWTH OF 6.5 TO 7.5 PERCENT.FORECASTS NET SPECIFIED ITEMS FOR FULL YEAR 2019 OF $1.35 PER SHARE.QTRLY TOTAL NUTRITION SALES OF $1,777 MILLION VERSUS $1,784 MILLION REPORTED LAST YEAR.FORECASTS SPECIFIED ITEMS FOR Q1 2019 OF $0.35 PER SHARE.FY2019 EARNINGS PER SHARE VIEW $3.20, REVENUE VIEW $32.15 BILLION -- REFINITIV IBES DATA.Q1 EARNINGS PER SHARE VIEW $0.64 -- REFINITIV IBES DATA.QTRLY TOTAL DIAGNOSTICS SALES OF $1,961 MILLION VERSUS $1,906 MILLION REPORTED LAST YEAR.SAYS CO IS "VERY WELL-POSITIONED HEADING INTO 2019".